I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Biomarkers Associated with Regorafenib First-Line Treatment..:
Elisa Conde
;
Julie Earl
;
Lorena Crespo-Toro
...
https://www.mdpi.com/2072-6694/13/7/1710. , 2021
Link:
https://doi.org/10.3390/cancers13071710
RT Journal T1
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:c5d09e0d48e94be49c90d050d53d1f86&Exemplar=1&LAN=DE A1 Elisa Conde A1 Julie Earl A1 Lorena Crespo-Toro A1 Carolina Blanco-Agudo A1 Edurne Ramos-Muñoz A1 E. Macarena Rodríguez-Serrano A1 Jose Carlos Martínez Ávila A1 Laura Salinas-Muñoz A1 Silvia Serrano-Huertas A1 Reyes Ferreiro A1 Mercedes Rodriguez-Garrote A1 Bruno Sainz A1 Bartomeu Massuti A1 Pilar García Alfonso A1 Manuel Benavides A1 Enrique Aranda A1 María Laura García-Bermejo A1 Alfredo Carrato PB MDPI AG YR 2021 K1 miRNAs K1 colorectal cancer K1 regorafenib K1 biomarkers K1 treatment response K1 toxicity K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/13/7/1710 LK http://dx.doi.org/https://doi.org/10.3390/cancers13071710 DO https://doi.org/10.3390/cancers13071710 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)